Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

JPMorgan, Standard Chartered win approval to expand in China

Published 01/19/2023, 06:23 AM
Updated 01/19/2023, 10:56 PM
© Reuters. FILE PHOTO: A JPMorgan logo is seen in New York City, U.S., January 10, 2017. REUTERS/Stephanie Keith/

SHANGHAI (Reuters) - JPMorgan (NYSE:JPM) and Standard Chartered (OTC:SCBFF) won Chinese regulatory approval on Thursday to expand operations in China as it encourages expansion by foreign companies after lifting its restrictive COVID-19 policies.

China is speeding up the process of granting permission to foreign institutions to boost the confidence of overseas investors as part of efforts to revive its economy battered by the COVID measures, which were scrapped last month.

JPMorgan's asset management arm will be allowed to take full ownership of China International Fund Management Co. (CIFM), in which it holds a 49% stake, the China Securities Regulatory Commission (CSRC) said.

The approval came more than two years after the U.S. bank had applied to buy out CIFM, in 2020.

JPMorgan Asset Management (JPMAM) said that CIFM, which overseas client assets of roughly 170 billion yuan ($25.10 billion), would be integrated into its global operating model.

"Our strategic goal is to significantly grow JPMAM China to become the leading foreign asset manager in China and contribute to JPMAM becoming the leading manager of China assets to global investors," Dan Watkins, its Asia Pacific chief executive officer, said in a statement.

"Symbolically it's very important, given both the size of the deal, and also the fact that China is meant to be one of JPMorgan's primary growth engines moving forward," said Peter Alexander, managing director of fund consultancy Z-Ben Advisors, which estimates the deal to be worth about $1 billion.

STANDARD CHARTERED

Also on Thursday, British bank Standard Chartered won an approval to set up a new securities brokerage unit in China, the CSRC said.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Chinese regulators and government officials were preoccupied with the zero-COVID policy in 2022, and preparation for October's 20th Communist Party Congress, but approvals granted to foreign institutions have recently picked up pace, Z-Ben's Alexander said.

The CSRC gave a green light to Schroders (LON:SDR) on Jan. 13, allowing the British asset manager to expand its footprint in China by setting up a mutual fund unit.

Canada's Manulife Financial (NYSE:MFC) Corp in November received regulatory approval to take full control of its Chinese mutual fund venture. The same month, U.S. asset manager Neuberger Berman won approval to set up a fund unit in China.

JPMorgan said that CIFM would be operating under the JPMAM brand and its China private fund unit would also be integrated into JPMAM China as it consolidates onshore operations.

Watkins said that integrating CIFM's domestic expertise with JPMorgan's resources and global scale "creates powerful momentum".

($1 = 6.7738 Chinese yuan renminbi)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.